Elizabeth C. M. de Lange

According to our database, Elizabeth C. M. de Lange authored at least 5 papers between 2010 and 2023.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2023

Biochemical reaction network topology defines dose-dependent Drug-Drug interactions.

Mehrad Babaei, Tom M. J. Evers, Fereshteh Shokri, Lucia Altucci, Elizabeth C. M. de Lange, Alireza Mashaghi

Comput. Biol. Medicine, March, 2023

2011

Simultaneous in vivo measurements of receptor density and affinity using [¹¹C]flumazenil and positron emission tomography: Comparison of full saturation and steady state methods.

Stina Syvänen, Elizabeth C. M. de Lange, Yoshihiko Tagawa, Maarten Schenke, Carla F. M. Molthoff, Albert D. Windhorst, Adriaan A. Lammertsma, Rob A. Voskuyl

NeuroImage, 2011

(R)-[¹¹C]Verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus.

Stina Syvänen, Gert Luurtsema, Carla F. M. Molthoff, Albert D. Windhorst, Marc C. Huisman, Adriaan A. Lammertsma, Rob A. Voskuyl, Elizabeth C. M. de Lange

BMC Medical Imaging, 2011

2010

Initial PET studies in rats with novel radiotracer [11C]D617 and comparison with (R)-[11C]verapamil.

Joost Verbeek, Stina Syvänen, Gert Luurtsema, Elizabeth C. M. de Lange, Jonas Eriksson, Albert D. Windhorst, Adriaan A. Lammertsma

NeuroImage, 2010

Comparison of two methods for estimating B_max and K_D of [¹¹C]flumazenil in rat brain.

Stina Syvänen, Elizabeth C. M. de Lange, Yoshihiko Tagawa, Maarten Schenke, Carla F. M. Molthoff, Albert D. Windhorst, Adriaan A. Lammertsma, Rob A. Voskuyl

NeuroImage, 2010